» Articles » PMID: 25485912

The Ashwell-Morell Receptor Regulates Hepatic Thrombopoietin Production Via JAK2-STAT3 Signaling

Overview
Journal Nat Med
Date 2014 Dec 9
PMID 25485912
Citations 133
Authors
Affiliations
Soon will be listed here.
Abstract

The hepatic Ashwell-Morell receptor (AMR) can bind and remove desialylated platelets. Here we demonstrate that platelets become desialylated as they circulate and age in blood. Binding of desialylated platelets to the AMR induces hepatic expression of thrombopoietin (TPO) mRNA and protein, thereby regulating platelet production. Endocytic AMR controls TPO expression through Janus kinase 2 (JAK2) and the acute phase response signal transducer and activator of transcription 3 (STAT3) in vivo and in vitro. Recognition of this newly identified physiological feedback mechanism illuminates the pathophysiology of platelet diseases, such as essential thrombocythemia and immune thrombocytopenia, and contributes to an understanding of the mechanisms of thrombocytopenia observed with JAK1/2 inhibition.

Citing Articles

The function of T cells in immune thrombocytopenia.

Bu S, Liu M, Yang L, Lee P, Miller H, Park C Front Immunol. 2025; 16:1499014.

PMID: 40061938 PMC: 11885273. DOI: 10.3389/fimmu.2025.1499014.


Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia.

Evangelidis P, Tragiannidis K, Gavriilaki E, Tragiannidis A Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852180 PMC: 11763769. DOI: 10.3390/cimb47010065.


Desialylation and Apoptosis in Immune Thrombocytopenia: Implications for Pathogenesis and Treatment.

Zheng S, Perdomo J Curr Issues Mol Biol. 2024; 46(11):11942-11956.

PMID: 39590303 PMC: 11592706. DOI: 10.3390/cimb46110709.


LMAN1 serves as a cargo receptor for thrombopoietin.

Everett L, Lin Z, Friedman A, Tang V, Myers G, Balbin-Cuesta G JCI Insight. 2024; 9(24).

PMID: 39499573 PMC: 11665562. DOI: 10.1172/jci.insight.175704.


Discovery of an unconventional lamprey lymphocyte lineage highlights divergent features in vertebrate adaptive immune system evolution.

Huang Y, Liu X, Li S, Li C, Wang H, Liu Q Nat Commun. 2024; 15(1):7626.

PMID: 39227584 PMC: 11372201. DOI: 10.1038/s41467-024-51763-2.


References
1.
Shinjo K, Takeshita A, Nakamura S, Naitoh K, Yanagi M, Tobita T . Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia. Leukemia. 1998; 12(3):295-300. DOI: 10.1038/sj.leu.2400946. View

2.
LaFave L, Levine R . JAK2 the future: therapeutic strategies for JAK-dependent malignancies. Trends Pharmacol Sci. 2012; 33(11):574-82. DOI: 10.1016/j.tips.2012.08.005. View

3.
Qian S, Fu F, Li W, Chen Q, de Sauvage F . Primary role of the liver in thrombopoietin production shown by tissue-specific knockout. Blood. 1998; 92(6):2189-91. View

4.
Griesshammer M, Hornkohl A, Nichol J, Hecht T, Raghavachar A, Heimpel H . High levels of thrombopoietin in sera of patients with essential thrombocythemia: cause or consequence of abnormal platelet production?. Ann Hematol. 1998; 77(5):211-5. DOI: 10.1007/s002770050445. View

5.
Vitrat N, Titeux M, Vainchenker W, Wendling F . High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin. Blood. 1999; 93(9):2859-66. View